S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Oramed PharmaceuticalsCocrystal PharmaBetterLife PharmaAvenue TherapeuticsVascular Biogenics
SymbolNASDAQ:ORMPNASDAQ:COCPOTCMKTS:PVOTFNASDAQ:ATXINASDAQ:VBLT
Price Information
Current Price$9.04$1.58N/A$5.18$1.85
52 Week RangeBuyBuyN/AHoldBuy
MarketRank™
Overall Score1.31.40.51.01.3
Analysis Score3.53.50.02.03.5
Community Score3.12.92.62.22.4
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.00.60.00.60.6
Analyst Ratings
Consensus RecommendationBuyBuyN/AHoldBuy
Consensus Price Target$13.33$4.75N/A$6.00$4.13
% Upside from Price Target47.49% upside200.63% upsideN/A15.83% upside122.97% upside
Trade Information
Market Cap$265.51 million$108.33 million$102.59 million$86.76 million$88.61 million
Beta1.981.46N/A0.711.17
Average Volume739,7013,785,01352,703128,4051,452,360
Sales & Book Value
Annual Revenue$2.71 million$6.56 millionN/AN/A$560,000.00
Price / Sales97.9716.51N/AN/A158.23
CashflowN/A$1.32 per shareN/AN/AN/A
Price / CashN/A1.20N/AN/AN/A
Book Value$1.40 per share$0.73 per share$0.01 per share$0.41 per share$1.00 per share
Price / Book6.462.16N/AN/A1.85
Profitability
Net Income$-11,510,000.00$-48,170,000.00$-14,780,000.00$-25,910,000.00$-19,460,000.00
EPS($0.56)($0.06)N/A($1.65)($0.54)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-424.76%-2,938.09%N/AN/A-2,692.41%
Return on Equity (ROE)-45.93%-25.81%-205.15%-192.35%-61.77%
Return on Assets (ROA)-30.33%-23.98%-147.23%-151.39%-47.23%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current Ratio8.93%12.59%3.62%3.89%5.16%
Quick Ratio8.93%12.59%3.62%3.89%5.16%
Ownership Information
Institutional Ownership Percentage6.03%18.71%N/A16.39%4.50%
Insider Ownership Percentage16.10%10.80%34.77%4.00%N/A
Miscellaneous
EmployeesN/A11N/A438
Shares Outstanding29.37 million68.56 million171.41 million16.75 million47.90 million
Next Earnings Date4/5/2021 (Estimated)3/26/2021 (Estimated)N/A3/29/2021 (Estimated)3/18/2021 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.